Entities / Company
Erasca (United States).
company in San Diego, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 13
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
Erasca, a company focused on therapies for RAS-driven cancers, received FDA clearance for its IND applications.Some support3 reports
-
EVgo operates a direct current fast charging network in the United States, concurrent with the FDA granting clearance for an investigational drug targeting KRAS-mutant tumors.Some support1 report
-
Erasca participated in a conference hosted by Morgan Stanley on September 2, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Erasca (United States) this week
News at the entities that move Erasca (United States) most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Erasca (United States)
Connections
The 3 strongest of 13, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA formally regulates and clears investigational drug applications for Erasca.
-
Jonathan E. Lim Structural
Jonathan E. Lim serves as the CEO and Chairman of Erasca.
-
Ras Operational
Erasca focuses on developing therapies specifically targeting the RAS pathway for cancer treatment.
History
Events by the month they beganJune 2026
3 events- Erasca, a company focused on therapies for RAS-driven cancers, received FDA clearance for its IND applications.
- EVgo operates a direct current fast charging network in the United States, concurrent with the FDA granting clearance for an investigational drug targeting KRAS-mutant tumors.
- Erasca participated in a conference hosted by Morgan Stanley on September 2, 2025.